Amphotericin B-loaded polyphenolic nanoparticles for synchronous fungal eradication and immunomodulation in treating superficial fungal infections
Materials Today Bio · 2026-12 · 41 · 103707
DOI: 10.1016/j.mtbio.2026.103707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2026-12. Verfasst von Yongnan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, PR China. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Fungal infection represents an escalating global health threat, yet effective treatment remains clinically challenging due to the poor solubility, limited bioavailability, and pronounced cytotoxicity of conventional antifungal agents. To overcome these limitations, a self-assembled nanoparticle (ATE NPs) is developed by integrating amphotericin B (AmB), epigallocatechin gallate (EGCG), and tri(phenylboronic acid)-derived crosslinker pentamethyldiethylenetriamine (T-PBA) for efficient fungal eradication and accelerated tissue repair. Benefiting from the strong affinity of T-PBA towards fungal cell wall polysaccharides, ATE NPs exhibit targeted adhesion and prolonged retention at infected lesions. Within the infection-associated mildly acidic microenvironment, the cleavage of boronate ester bonds triggers the controlled release of AmB, disrupting fungal membranes and eliminating pathogens. Meanwhile, EGCG exerts potent anti-inflammatory and pro-healing effects to promote tissue regeneration. Consequently, ATE NPs exhibit robust mucoadhesion, superior antifungal activity, and remarkable wound-healing capabilities both in vitro and in vivo. In murine models of fungal keratitis and cutaneous mycosis, the multifunctional nanosystem effectively suppresses fungal proliferation, mitigates corneal inflammatory damage and accelerates healing. Furthermore, transcriptomic analysis reveals that ATE NPs induce fungal metabolic dysregulation and oxidative stress while favorably modulating host immune responses. Overall, this work provides a promising, biocompatible nanotherapeutic strategy for the integrated management of severe superficial fungal infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, PR China.
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310058, PR China.
- Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, 310009, PR China.
- Department of Cardiology, Zhejiang Key Laboratory of Cardiovascular Intervention and Precision Medicine, Engineering Research Center for Cardiovascular Innovative Devices of Zhejiang Province, Sir Run Run Shaw Hospital,…
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Chen, F., Wang, S., Dai, W., Jin, Q., Jia, F., & Ye, Y. (2026). Amphotericin B-loaded polyphenolic nanoparticles for synchronous fungal eradication and immunomodulation in treating superficial fungal infections. Materials Today Bio, 41, 103707. https://doi.org/10.1016/j.mtbio.2026.103707
Vancouver
Chen Y, Chen F, Wang S, Dai W, Jin Q, Jia F, et al. Amphotericin B-loaded polyphenolic nanoparticles for synchronous fungal eradication and immunomodulation in treating superficial fungal infections. Materials Today Bio. 2026;41:103707. doi:10.1016/j.mtbio.2026.103707
BibTeX
@article{Chen2026,
author = {Chen, Yongnan and Chen, Fuyao and Wang, Shiya and Dai, Wenbin and Jin, Qiao and Jia, Fan and Ye, Yang},
title = {Amphotericin B-loaded polyphenolic nanoparticles for synchronous fungal eradication and immunomodulation in treating superficial fungal infections},
journal = {Materials Today Bio},
year = {2026},
volume = {41},
pages = {103707},
doi = {10.1016/j.mtbio.2026.103707}
}
EUVIMED